| Determinants and clinical outcome of uptitration of ACE-inhibitors and beta-blockers in patients with heart failure: a prospective European study W Ouwerkerk, AA Voors, SD Anker, JG Cleland, K Dickstein, G Filippatos, ... European heart journal 38 (24), 1883-1890, 2017 | 404 | 2017 |
| Factors influencing the predictive power of models for predicting mortality and/or heart failure hospitalization in patients with heart failure W Ouwerkerk, AA Voors, AH Zwinderman JACC: Heart Failure 2 (5), 429-436, 2014 | 385 | 2014 |
| Development and validation of multivariable models to predict mortality and hospitalization in patients with heart failure AA Voors, W Ouwerkerk, F Zannad, DJ van Veldhuisen, NJ Samani, ... European journal of heart failure 19 (5), 627-634, 2017 | 253 | 2017 |
| Identifying pathophysiological mechanisms in heart failure with reduced versus preserved ejection fraction J Tromp, BD Westenbrink, W Ouwerkerk, DJ van Veldhuisen, NJ Samani, ... Journal of the American College of Cardiology 72 (10), 1081-1090, 2018 | 245 | 2018 |
| The clinical significance of interleukin‐6 in heart failure: results from the BIOSTAT‐CHF study G Markousis‐Mavrogenis, J Tromp, W Ouwerkerk, M Devalaraja, ... European journal of heart failure 21 (8), 965-973, 2019 | 238 | 2019 |
| A systematic review and network meta-analysis of pharmacological treatment of heart failure with reduced ejection fraction J Tromp, W Ouwerkerk, DJ van Veldhuisen, HL Hillege, AM Richards, ... Heart Failure 10 (2), 73-84, 2022 | 208 | 2022 |
| Identifying optimal doses of heart failure medications in men compared with women: a prospective, observational, cohort study BT Santema, W Ouwerkerk, J Tromp, IE Sama, A Ravera, ... The Lancet 394 (10205), 1254-1263, 2019 | 207 | 2019 |
| Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study. TK Teng, J Tromp, WT Tay, I Anand, W Ouwerkerk, V Chopra, GS Wander, ... Lancet Glob Health 6, e1008-e1018, 2018 | 157* | 2018 |
| Multimorbidity in patients with heart failure from 11 Asian regions: a prospective cohort study using the ASIAN-HF registry J Tromp, WT Tay, W Ouwerkerk, THK Teng, J Yap, MR MacDonald, ... PLoS medicine 15 (3), e1002541, 2018 | 151 | 2018 |
| Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): a cohort study J Tromp, S Bamadhaj, JGF Cleland, CE Angermann, U Dahlstrom, ... The Lancet Global Health 8 (3), e411-e422, 2020 | 148 | 2020 |
| Automated interpretation of systolic and diastolic function on the echocardiogram: a multicohort study J Tromp, PJ Seekings, CL Hung, MB Iversen, MJ Frost, W Ouwerkerk, ... The Lancet Digital Health 4 (1), e46-e54, 2022 | 89 | 2022 |
| Machine learning based on biomarker profiles identifies distinct subgroups of heart failure with preserved ejection fraction RJ Woolley, D Ceelen, W Ouwerkerk, J Tromp, SM Figarska, SD Anker, ... European journal of heart failure 23 (6), 983-991, 2021 | 86 | 2021 |
| Microvascular disease in patients with diabetes with heart failure and reduced ejection versus preserved ejection fraction J Tromp, SL Lim, WT Tay, THK Teng, C Chandramouli, W Ouwerkerk, ... Diabetes Care 42 (9), 1792-1799, 2019 | 73 | 2019 |
| Concentric vs. eccentric remodelling in heart failure with reduced ejection fraction: clinical characteristics, pathophysiology and response to treatment JF Nauta, YM Hummel, J Tromp, W Ouwerkerk, P van der Meer, X Jin, ... European journal of heart failure 22 (7), 1147-1155, 2020 | 70 | 2020 |
| Fibroblast growth factor 23 is related to profiles indicating volume overload, poor therapy optimization and prognosis in patients with new-onset and worsening heart failure JM Ter Maaten, AA Voors, K Damman, P van der Meer, SD Anker, ... International journal of cardiology 253, 84-90, 2018 | 66 | 2018 |
| Novel endotypes in heart failure: effects on guideline-directed medical therapy J Tromp, W Ouwerkerk, BG Demissei, SD Anker, JG Cleland, K Dickstein, ... European Heart Journal 39 (48), 4269-4276, 2018 | 56 | 2018 |
| Hyperkalemia and treatment with RAAS inhibitors during acute heart failure hospitalizations and their association with mortality JC Beusekamp, J Tromp, JGF Cleland, MM Givertz, M Metra, ... JACC: Heart Failure 7 (11), 970-979, 2019 | 45 | 2019 |
| Biomarker-guided versus guideline-based treatment of patients with heart failure: results from BIOSTAT-CHF W Ouwerkerk, AH Zwinderman, LL Ng, B Demissei, HL Hillege, F Zannad, ... Journal of the American College of Cardiology 71 (4), 386-398, 2018 | 40 | 2018 |
| Effects of combined renin–angiotensin–aldosterone system inhibitor and beta‐blocker treatment on outcomes in heart failure with reduced ejection fraction: insights from BIOSTAT … W Ouwerkerk, THK Teng, J Tromp, WT Tay, JG Cleland, ... European journal of heart failure 22 (8), 1472-1482, 2020 | 33 | 2020 |
| Distinct pathological pathways in patients with heart failure and diabetes J Tromp, AA Voors, A Sharma, JP Ferreira, W Ouwerkerk, HL Hillege, ... Heart Failure 8 (3), 234-242, 2020 | 31 | 2020 |
